Cibien Drugs And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.53 M
- Company Age 31 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.70 M
- Revenue Growth %
- Profit Growth -33.27%
- Ebitda -88.62%
- Net Worth 0.52%
- Total Assets -0.21%
About Cibien Drugs And Pharmaceuticals
Cibien Drugs And Pharmaceuticals Pvt Ltd (CDAPPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 July 1993 and has a history of 31 years and six months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.53 M.
The company currently has active open charges totaling ₹7.70 M.
Himanshu Bhatt, Atul Bhopale, and Manan Bhatt serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230MH1993PTC073218
-
Company No.
073218
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Jul 1993
-
Date of AGM
12 Aug 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Cibien Drugs And Pharmaceuticals?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Himanshu Bhatt | Director | 29-Jul-1993 | Current |
Atul Bhopale | Director | 27-May-2024 | Current |
Manan Bhatt | Director | 07-Mar-2019 | Current |
Financial Performance of Cibien Drugs And Pharmaceuticals.
Cibien Drugs And Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 33.27% decrease in profit. The company's net worth moved up by a moderate rise of 0.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Cibien Drugs And Pharmaceuticals?
In 2020, Cibien Drugs And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹7.70 M
₹0
Charges Breakdown by Lending Institutions
- The Sharao Vithal Co-Op Bank Ltd; : 0.77 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
31 Mar 2003 | The Sharao Vithal Co-Op Bank Ltd; | ₹1.20 M | Open |
04 Jun 1999 | The Sharao Vithal Co-Op Bank Ltd; | ₹2.50 M | Open |
16 Jun 1998 | The Sharao Vithal Co-Op Bank Ltd; | ₹2.00 M | Open |
29 Jul 1997 | The Sharao Vithal Co-Op Bank Ltd; | ₹1.00 M | Open |
09 Jul 1996 | The Sharao Vithal Co-Op Bank Ltd; | ₹1.00 M | Open |
How Many Employees Work at Cibien Drugs And Pharmaceuticals?
Unlock and access historical data on people associated with Cibien Drugs And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cibien Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cibien Drugs And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.